Protagonist Therapeutics PTGX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's enterprise value?
- Protagonist Therapeutics (PTGX) reported enterprise value of $6.54B in Q1 2026.
- How has Protagonist Therapeutics's enterprise value changed year-over-year?
- Protagonist Therapeutics's enterprise value increased by 130.3% year-over-year, from $2.84B to $6.54B.
- What is the long-term trend for Protagonist Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's enterprise value has grown at a 44.4% compound annual growth rate (CAGR), from $850.8M to $5.34B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.